Evidence map›Paper›PMID 38018464›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2024

Copper-Mediated N-Trifluoromethylation of O-Benzoylhydroxylamines.

Thomas D Fleetwood, William J Kerr, Joseph Mason

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. A mild and practical approach to N-CFNature communications · 2025
    Article
  3. Copper-Mediated N-Trifluoromethylation of O-Benzoylhydroxylamines.Chemistry (Weinheim an der Bergstrasse, Germany) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Thomas D FleetwoodMedicinal Chemistry, GSK Medicines Research Centre, Gunnels Wood Road, SG1 2NY, Stevenage, England, U.K.ORCID https://orcid.org/0009-0003-8937-8164
William J KerrDepartment of Pure and Applied Chemistry, University of Strathclyde, G1 1XL, Glasgow, Scotland, U.K.ORCID https://orcid.org/0000-0002-1332-785X
Joseph MasonMedicinal Chemistry, GSK Medicines Research Centre, Gunnels Wood Road, SG1 2NY, Stevenage, England, U.K.ORCID https://orcid.org/0000-0003-0062-2339

Funding

Engineering and Physical Sciences Research Council EP/S035990/1GlaxoSmithKline GSK/University of Strathclyde Collaborative PhD Programme Studentship
6 · The paper itself

Abstract

The use of trifluoromethyl containing compounds is well established within medicinal chemistry, with a range of approved drugs containing C-CF

Indexed as

AminationCatalysisCopperN-TrifluoromethylaminesTrifluoromethyl

Identifiers

PMID38018464
PMCPMC10952365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.